In order to function properly, neurons must maintain their microenvironment under tight homeostatic control. Therefore, they are sealed off from the rest of the organism by a ''blood-brain barrier'' (BBB). It has been long assumed that this physical barrier is created largely by endothelial cells (ECs) in the central nervous system (CNS), while the role of pericytes (PCs), i.e., mural cells that surround and stabilize these vessels, has remained more enigmatic. In fact, it has been hypothesized that astrocytes, which are also part of the neurovascular unit, are more important in inducing this barrier. Furthermore, although multiple neurodegenerative disorders are characterized by vascular anomalies, it has remained puzzling whether these vascular changes are cause or consequence of the neurological disease. In this issue, Bell et al. (2010) report that a progressive age-dependent loss of PCs around brain microvessels impairs brain perfusion, disturbs vasoreactivity, and induces pathological BBB leakiness, altogether leading to neuronal damage, learning deficits, neurodegeneration and neuroinflammation during aging. Coincidently, two other papers in Nature report complementary findings that PCs are more important than expected in establishing the BBB during development and in maintaining the BBB integrity in adulthood (Armulik et al., 2010; Daneman et al., 2010) . Three papers thus independently show that PCs are not simply passive bystanders in the CNS but actively contribute as critical gatekeepers to safeguard the neuronal milieu (Figure 1 ).
More than a century ago, Paul Ehrlich (1885) discovered that dyes, injected into the blood, accumulated in most organs except in the brain (Díaz-Flores et al., 2009 ). Based on this seminal observation, it was postulated that a BBB shielded the brain from toxic circulating substances. The BBB constitutes a physical, metabolic, and transport barrier, restricting traffic of nutrients and other molecules in and out the brain. One of the primary functions of the BBB is to maintain the ionic homeostasis around synapses. In fact, preserving this ionic microenvironment is believed to represent the evolutionary selective pressure and advantage for developing a barrier in the nervous system (Abbott, 2005) .
In avascular invertebrates, such as insects and crustaceans, the BBB is formed by glial cells. Later in evolution, when the brain enlarged in size and became more active, blood vessels developed to nourish every neuron with its own supply. However, as a possible consequence of this vascularization, synapses would become exposed to substances in the blood and thereby lose their ionic homeostasis. To protect neurons, it was thus necessary that ECs took over the role of glial cells as ''first-line'' barrier and established BBB properties (Abbott, 2005) . While most previous studies have focused on the role of ECs and astrocytes in the control of the BBB, the in vivo role of PCs in the maintenance of the BBB and in preserving the synaptic homeostasis in adulthood has remained elusive.
But what sort of cells are PCs precisely, and what is their role in establishing the BBB? Derived from the Greek word ''kytos'' (hollow vessel), pericytes surround small vessels. Originally discovered by Rouget in the late 1800s, PCs ensheath ECs and lie embedded in a basement membrane, which they share with ECs (Zlokovic, 2008) . They have an elongated stellate-shape, extend fingertip-like processes that cover adjacent ECs in an umbrella-like fashion, and establish close physical interactions via peg-socket contacts (Díaz-Flores et al., 2009) . Outside the brain, PCs originate from mesenchymal progenitors, but within the brain, they arise from the neural crest as well. Interestingly, vessel coverage by PCs is greater in tissues with a slow EC turnover and is the highest in the CNS (Díaz-Flores et al., 2009; Zlokovic, 2008) . PCs are multitasking cells with a remarkable plasticity and range of activities: they promote vessel stabilization by providing structural integrity and inducing EC quiescence; they regulate vascular tone and tissue perfusion; and they can also act as macrophage-like scavengers and serve as progenitors of various cell types, including of neurons and astrocytes in vitro. However, it was not known whether PCs are critical to maintain the BBB integrity in adulthood and, conversely, whether PC deficiency would result in functional neuronal deficit.
For nascent vessels to mature, ECs must become covered by PCs and therefore release signals to recruit PCs. Plateletderived growth factor B (PDGF-B) is an important recruitment cue for PCs, which express the PDGFRß receptor. Hence, various types of PDGF (Rß) ) with disrupted PDGF-B binding to heparin-rich matrix or mice lacking PDGF-B selectively in their ECs have fewer PCs and exhibit signs of excessive vessel growth in the retina, similar to diabetic retinopathies (Enge et al., 2002; Gaengel et al., 2009; Lindblom et al., 2003) . Mice expressing PDGF-B only in ECs (R26 +/0 ) (Armulik et al., 2010) or PDGFRß F7/F7 mice, homozygous for 7 signaling mutations (Tallquist et al., 2003) , also have fewer PCs. PDGFRß signaling is of general importance for PC recruitment in other organs as well (Gaengel et al., 2009) . Daneman et al. (2010) Bell et al. (2010) also noticed another progressive age-dependent defect in their PDGFRß mutant mice, i.e., vascular regression leading to hypoperfusion and insufficient oxygenation of brain regions. This regression presumably occurs because ECs in these PC-deficient mice are deprived of trophic support from PCproduced molecules, such as VEGF, angiopoietin-1, and others, known to promote EC survival (Krueger and Bechmann, 2010 ). In addition, vasoregulation in the brain was also impaired in the PDGFRß hypomorph strains. Thus, upon progressive disappearance of PCs, both structural and functional vessel defects impair perfusion and oxygenation of the CNS.
What are the long-term consequences of the progressive BBB leakiness and perfusion deficit? Similar vascular defects have been reported in various types of neurodegenerative disorders, but, in many cases, it is uncertain if these changes are cause or consequence of the disease (Quaegebeur and Carmeliet, 2010) . A remarkable finding by Bell et al. (2010) therefore is that aging mice with progressive PC loss develop a neurodegenerative phenotype with neuronal loss, reduced dendritic length and density in the hippocampus and cortex, and impaired hippocampal learning and spatial memory. Since the vascular changes precede the onset of neurodegeneration by months, the neuronal injury is likely a consequence of the compromised brain microcirculation and BBB disruption.
How can vascular abnormalities upon PC loss trigger neurodegeneration? First, hypoperfusion impairs oxygen and nutrient supply. Isolated perfusion defects without accompanying BBB disruption in Meox-2-haplodeficient mice sufficed to cause neuron loss, albeit to a lesser extent than the PC-deficient models (Bell et al., 2010) . Hypoxia impairs neuronal function and survival and can facilitate constriction of residual PCs, thereby further declining perfusion. It is (Bottom) Upon pericyte loss, vessels regress and loose their vasoreactivity, leading to hypoperfusion and hypoxia. In addition, the BBB breaks down, possibly as a result of abnormal endothelial junctions, transcytosis, and astrocyte polarization, resulting in leakage of neurotoxic substances. Both mechanisms precede neuronal damage. also likely that, because of the impaired vasoregulation, nutrient supply cannot be dynamically adjusted to the changing metabolic needs (Hamilton et al., 2010) . A second mechanism is that BBB breakdown causes neuronal injury via leakage of neurotoxic molecules into the brain parenchyma and impedes clearance of waste (Zlokovic, 2008) . The leakiness can also result in inflammation and brain edema, impairing oxygen delivery even further. Third, diminished production of neurotrophic factors by PCs may contribute to neuronal loss. Finally, PCs are known to possess neural stem cell capacity in vitro (Krueger and Bechmann, 2010) , raising a more speculative question of whether neuronal regeneration is also defective in the PC-deficient mice.
These insights are of great importance. Neurovascular dysfunction is being increasingly documented in a range of neurodegenerative disorders. For instance, reduced microvessel density, cerebral hypoperfusion, and impaired vessel reactivity have been documented in Alzheimer's disease (Quaegebeur and Carmeliet, 2010; Zlokovic, 2008) . The development of an adult-onset motor neuron disease phenotype in a mouse with reduced VEGF levels and perfusion deficits also suggests a causal involvement of chronic vascular insufficiency in amyotrophic lateral sclerosis (ALS) (Quaegebeur and Carmeliet, 2010) . Blood-spinal-cord barrier defects have been also demonstrated in ALS (Zhong et al., 2008) . The Bell et al. (2010) findings that the vascular defects precede neurodegeneration provide an initial answer to the highly debated question of whether cerebrovascular defects can causally contribute to neurodegeneration (Quaegebeur and Carmeliet, 2010; Zlokovic, 2008) . These three studies also imply that PC deficiency might perhaps be a more common denominator of various sorts of neurovascular disorders than previously suspected and warrant further exploration of the role of PCs in human neurodegeneration, an area of research that has been largely neglected so far.
As is often the case, these novel data raise a number of additional questions. For instance, how do PCs regulate the BBB integrity (Figure 1) ? Daneman et al. (2010) propose that PCs are not necessary for the expression of BBB-specific genes in ECs but that they release a number of factors (such as angiopoietin-1) to maintain the BBB integrity and to suppress transcytosis. Armulik et al. (2010) also did not see marked changes in BBB gene expression but noticed abnormal polarization of astrocyte end-feet, suggesting that PCs, which are partially sandwiched between ECs and astrocytes in the neurovascular unit, orchestrate bidirectional communications between cells of the unit. In contrast, Bell et al. (2010) documented an age-dependent downregulation of several BBB genes but no difference in astrocyte marker expression. It remains to be determined whether these divergent findings are due to differences in the PDGF(Rß)-deficient strains used, to technical analysis, or to differences between development versus aging.
Another question is whether PDGFRß is truly only expressed in PCs and not in other neural cells as well, as loss of PDGFRß in these cells might then also contribute to neurodegeneration; genetic studies to conditionally ablate PDGFRß specifically in PCs or other cells might help to address this question. Also, to what extent are the neurological deficits attributable to neurodegeneration or, perhaps, to the vascular lesions? Indeed, in CADASIL (a human PC-deficient condition caused by progressive degeneration of mural cells), dementia is attributable to vascular microinfarcts in the white matter. Are the observed hypoperfusion and impaired vasoreactivity only due to a defect in PCs or are vascular smooth muscle cells, which are also targets of PDGF-B and regulate cerebral flow, in larger arterioles also affected? Given that PC defects already appear before birth in several of the PDGF(Rß) mutant lines used, would conditional ablation of PCs after birth result in the same neurodegenerative phenotype? Finally, as the blood-nerve barrier consists only of PCs (no astrocytes), is the functioning of the peripheral nervous system impaired in PC-deficient models as well?
The exciting findings that PCs are active safeguards of the BBB in the neurovascular unit should prime interest in both the vascular biology and neuroscience communities to further study the role of PCs in neurobiology in general and to explore the therapeutic potential of manipulating this intriguing cell type for neurovascular disorders.
